Bicara Therapeutics CEO (BICA) sells $354k in stock holdings

AI Summary

Bicara Therapeutics CEO Mazumdar sold $354,000 worth of the company’s stock. This transaction may indicate a change in confidence or strategy regarding the company's future. The sale could also affect investor sentiment and share price movements for Bicara Therapeutics (BICA). Monitoring such insider trading activities can be crucial for understanding potential market impacts.